RPT-UPDATE 3-France pulls Takeda diabetes drug on cancer fears
A recent article in the Chicago Tribune reports that patients using Lipitor, Actos, or Plavix may start enjoying savings of up to 90 percent as patents on those drugs expire. The three drugs comprise a significant T) top-selling diabetes pill Actos on Thursday because of concerns about cancer risks. The French Medicines Agency, or AFSSAPS, [...]